Hepatitis B Foundation Newsletter-March 2011 President's 2012 Budget

[Guest guest]

http://hepb.convio.net/site/MessageViewer?em_id=1641.0 & dlv_id=6122

Having trouble? View this message on our website.

Forward to a Friend | Donate | www.hepb.org |

March 2011

President Obama Prioritizes Viral Hepatitis in 2012 Budget

The Obama Administration released its 2012 budget that includes a $5 million

increase for the CDC’s Division of Viral Hepatitis to expand state surveillance,

screening and treatment programs for chronic infections. The White House

prioritization of chronic hepatitis represents a huge advocacy victory for the

community – including the Hepatitis B Foundation - which has worked tirelessly

to educate the White House and Congress about making HBV and HCV an urgent

national priority. Learn more.

Early Treatment of Chronic Hepatitis B Can Cut Deaths And Costs

Chronic hepatitis B infections affect up to two million Americans, yet the costs

and benefits of treatment have not been fully evaluated. Using a model for

simulating disease progression, Dr. Henry Pollack and colleagues at New York

University compared treatment programs for HBV that start at an early stage vs.

late stage. Their analysis concluded that early HBV care can improve health,

reduce premature deaths, and prevent expensive complications, making it highly

cost-effective in the long term. These results demonstrate the importance of

screening for HBV among at-risk groups and ensuring linkage to care for those

infected. Learn more.

New Recommendations for Infants Who Missed HBV Birth Dose

Guidance for administration of the HBV vaccine series for infants who did not

receive the recommended birth dose has been updated. A minimum age (i.e. birth)

has been added to the catch-up schedule, noting that the final dose in the HBV

series should be administered no earlier than 24 weeks of age. These 2011

recommendations have been approved by the Advisory Committee on Immunization

Practices of the CDC, American Academy of Pediatrics, and American Academy of

Family Physicians. Learn more.

Save the Date!

Chronic Viral Hepatitis Conference

June 4-5, Atlanta, GA

The AASLD and CDC are co-hosting a Single Topic Conference that will discuss

“Chronic Viral Hepatitis: Strategies to Improve Effectiveness of Screening and

Treatment.” The target audience includes providers, health care managers,

insurers, public health professionals, policy makers, industry representatives,

and patient advocates. Meeting directors include Drs. Ward, Lok,

, and Hashem B. El-Serag. Register today!

Stay Connected!

Don't Forget to follow us on: Facebook, Twitter, YouTube and LinkedIn

Celebrating 20 Years 1991 - 2011

SAVE THE DATE!

20th Anniversary

Crystal Ball

May 13, 2011

Sponsor, donate, or attend to support us!

Download Our 2010 Annual Report

Unsubscribe | Forward to a Friend | Visit our web site

3805 Old Easton Road, Doylestown, PA 18902 | Tel: 215.489.4900 | Email us at:

connect@...

Hepatitis B Foundation © 2011 All rights reserved.

[Guest guest]

http://hepb.convio.net/site/MessageViewer?em_id=1641.0 & dlv_id=6122

Having trouble? View this message on our website.

Forward to a Friend | Donate | www.hepb.org |

March 2011

President Obama Prioritizes Viral Hepatitis in 2012 Budget

The Obama Administration released its 2012 budget that includes a $5 million

increase for the CDC’s Division of Viral Hepatitis to expand state surveillance,

screening and treatment programs for chronic infections. The White House

prioritization of chronic hepatitis represents a huge advocacy victory for the

community – including the Hepatitis B Foundation - which has worked tirelessly

to educate the White House and Congress about making HBV and HCV an urgent

national priority. Learn more.

Early Treatment of Chronic Hepatitis B Can Cut Deaths And Costs

Chronic hepatitis B infections affect up to two million Americans, yet the costs

and benefits of treatment have not been fully evaluated. Using a model for

simulating disease progression, Dr. Henry Pollack and colleagues at New York

University compared treatment programs for HBV that start at an early stage vs.

late stage. Their analysis concluded that early HBV care can improve health,

reduce premature deaths, and prevent expensive complications, making it highly

cost-effective in the long term. These results demonstrate the importance of

screening for HBV among at-risk groups and ensuring linkage to care for those

infected. Learn more.

New Recommendations for Infants Who Missed HBV Birth Dose

Guidance for administration of the HBV vaccine series for infants who did not

receive the recommended birth dose has been updated. A minimum age (i.e. birth)

has been added to the catch-up schedule, noting that the final dose in the HBV

series should be administered no earlier than 24 weeks of age. These 2011

recommendations have been approved by the Advisory Committee on Immunization

Practices of the CDC, American Academy of Pediatrics, and American Academy of

Family Physicians. Learn more.

Save the Date!

Chronic Viral Hepatitis Conference

June 4-5, Atlanta, GA

The AASLD and CDC are co-hosting a Single Topic Conference that will discuss

“Chronic Viral Hepatitis: Strategies to Improve Effectiveness of Screening and

Treatment.” The target audience includes providers, health care managers,

insurers, public health professionals, policy makers, industry representatives,

and patient advocates. Meeting directors include Drs. Ward, Lok,

, and Hashem B. El-Serag. Register today!

Stay Connected!

Don't Forget to follow us on: Facebook, Twitter, YouTube and LinkedIn

Celebrating 20 Years 1991 - 2011

SAVE THE DATE!

20th Anniversary

Crystal Ball

May 13, 2011

Sponsor, donate, or attend to support us!

Download Our 2010 Annual Report

Unsubscribe | Forward to a Friend | Visit our web site

3805 Old Easton Road, Doylestown, PA 18902 | Tel: 215.489.4900 | Email us at:

connect@...

Hepatitis B Foundation © 2011 All rights reserved.

[Guest guest]

http://hepb.convio.net/site/MessageViewer?em_id=1641.0 & dlv_id=6122

Having trouble? View this message on our website.

Forward to a Friend | Donate | www.hepb.org |

March 2011

President Obama Prioritizes Viral Hepatitis in 2012 Budget

The Obama Administration released its 2012 budget that includes a $5 million

increase for the CDC’s Division of Viral Hepatitis to expand state surveillance,

screening and treatment programs for chronic infections. The White House

prioritization of chronic hepatitis represents a huge advocacy victory for the

community – including the Hepatitis B Foundation - which has worked tirelessly

to educate the White House and Congress about making HBV and HCV an urgent

national priority. Learn more.

Early Treatment of Chronic Hepatitis B Can Cut Deaths And Costs

Chronic hepatitis B infections affect up to two million Americans, yet the costs

and benefits of treatment have not been fully evaluated. Using a model for

simulating disease progression, Dr. Henry Pollack and colleagues at New York

University compared treatment programs for HBV that start at an early stage vs.

late stage. Their analysis concluded that early HBV care can improve health,

reduce premature deaths, and prevent expensive complications, making it highly

cost-effective in the long term. These results demonstrate the importance of

screening for HBV among at-risk groups and ensuring linkage to care for those

infected. Learn more.

New Recommendations for Infants Who Missed HBV Birth Dose

Guidance for administration of the HBV vaccine series for infants who did not

receive the recommended birth dose has been updated. A minimum age (i.e. birth)

has been added to the catch-up schedule, noting that the final dose in the HBV

series should be administered no earlier than 24 weeks of age. These 2011

recommendations have been approved by the Advisory Committee on Immunization

Practices of the CDC, American Academy of Pediatrics, and American Academy of

Family Physicians. Learn more.

Save the Date!

Chronic Viral Hepatitis Conference

June 4-5, Atlanta, GA

The AASLD and CDC are co-hosting a Single Topic Conference that will discuss

“Chronic Viral Hepatitis: Strategies to Improve Effectiveness of Screening and

Treatment.” The target audience includes providers, health care managers,

insurers, public health professionals, policy makers, industry representatives,

and patient advocates. Meeting directors include Drs. Ward, Lok,

, and Hashem B. El-Serag. Register today!

Stay Connected!

Don't Forget to follow us on: Facebook, Twitter, YouTube and LinkedIn

Celebrating 20 Years 1991 - 2011

SAVE THE DATE!

20th Anniversary

Crystal Ball

May 13, 2011

Sponsor, donate, or attend to support us!

Download Our 2010 Annual Report

Unsubscribe | Forward to a Friend | Visit our web site

3805 Old Easton Road, Doylestown, PA 18902 | Tel: 215.489.4900 | Email us at:

connect@...

Hepatitis B Foundation © 2011 All rights reserved.

[Guest guest]

http://hepb.convio.net/site/MessageViewer?em_id=1641.0 & dlv_id=6122

Having trouble? View this message on our website.

Forward to a Friend | Donate | www.hepb.org |

March 2011

President Obama Prioritizes Viral Hepatitis in 2012 Budget

The Obama Administration released its 2012 budget that includes a $5 million

increase for the CDC’s Division of Viral Hepatitis to expand state surveillance,

screening and treatment programs for chronic infections. The White House

prioritization of chronic hepatitis represents a huge advocacy victory for the

community – including the Hepatitis B Foundation - which has worked tirelessly

to educate the White House and Congress about making HBV and HCV an urgent

national priority. Learn more.

Early Treatment of Chronic Hepatitis B Can Cut Deaths And Costs

Chronic hepatitis B infections affect up to two million Americans, yet the costs

and benefits of treatment have not been fully evaluated. Using a model for

simulating disease progression, Dr. Henry Pollack and colleagues at New York

University compared treatment programs for HBV that start at an early stage vs.

late stage. Their analysis concluded that early HBV care can improve health,

reduce premature deaths, and prevent expensive complications, making it highly

cost-effective in the long term. These results demonstrate the importance of

screening for HBV among at-risk groups and ensuring linkage to care for those

infected. Learn more.

New Recommendations for Infants Who Missed HBV Birth Dose

Guidance for administration of the HBV vaccine series for infants who did not

receive the recommended birth dose has been updated. A minimum age (i.e. birth)

has been added to the catch-up schedule, noting that the final dose in the HBV

series should be administered no earlier than 24 weeks of age. These 2011

recommendations have been approved by the Advisory Committee on Immunization

Practices of the CDC, American Academy of Pediatrics, and American Academy of

Family Physicians. Learn more.

Save the Date!

Chronic Viral Hepatitis Conference

June 4-5, Atlanta, GA

The AASLD and CDC are co-hosting a Single Topic Conference that will discuss

“Chronic Viral Hepatitis: Strategies to Improve Effectiveness of Screening and

Treatment.” The target audience includes providers, health care managers,

insurers, public health professionals, policy makers, industry representatives,

and patient advocates. Meeting directors include Drs. Ward, Lok,

, and Hashem B. El-Serag. Register today!

Stay Connected!

Don't Forget to follow us on: Facebook, Twitter, YouTube and LinkedIn

Celebrating 20 Years 1991 - 2011

SAVE THE DATE!

20th Anniversary

Crystal Ball

May 13, 2011

Sponsor, donate, or attend to support us!

Download Our 2010 Annual Report

Unsubscribe | Forward to a Friend | Visit our web site

3805 Old Easton Road, Doylestown, PA 18902 | Tel: 215.489.4900 | Email us at:

connect@...

Hepatitis B Foundation © 2011 All rights reserved.